Evaluating severity and status in rheumatoid arthritis

Journal of Rheumatology

Volumn 28, Issue 6, 2001, Pages 1453-1462

  Wolfe, F ^a   O'Dell, J R ^a   Kavanaugh, A ^a   Wilske, K ^a   Pincus, T ^a  

^a ARTHRITIS RESEARCH CENTER FOUNDATION   (United States)

Author keywords

Disease activity; Disease status; Health assessment questionnaire; Joint counts; Joint examinations; Rheumatoid arthritis

Indexed keywords

CLINICAL PRACTICE; CLINICAL TRIAL; CONFERENCE PAPER; DIAGNOSTIC VALUE; DISEASE SEVERITY; HEALTH STATUS; HUMAN; METATARSOPHALANGEAL JOINT; PAIN ASSESSMENT; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; RELIABILITY; RHEUMATOID ARTHRITIS; VALIDATION PROCESS;

ARTHRITIS, RHEUMATOID; CLINICAL TRIALS; HUMANS; PHYSICAL EXAMINATION; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0034993010     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (99)

1. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years
2. Treatment of rheumatoid arthritis - Does it affect society's cost for the disease?
3. Employment patterns and their effect on health outcomes among women with rheumatoid arthritis followed for 7 years
4. Going beyond demographic characteristics in arthritis research: Reflections on process in the experience of arthritis
5. Psychological distress and rheumatic disease
6. Work disability in an inception cohort of patients with seropositive rheumatoid arthritis: A 20 year study
7. Work disability in rheumatoid arthritis 10 years after the diagnosis
8. The longterm outcomes of rheumatoid arthritis: Work disability: A prospective 18 year study of 823 patients
9. The occurrence of sick-leave in the first year of rheumatoid arthritis. A comparison with the members of the compulsory health insurance
10. Gender, paid work, and symptoms of emotional distress in rheumatoid arthritis patients
11. Work disability in early rheumatoid arthritis
12. Family work demands, employment demands and depressive symptoms in women with rheumatoid arthritis
13. Work disability among persons with musculoskeletal conditions
14. Modeling the lifetime costs of rheumatoid arthritis
15. Direct cost of rheumatoid arthritis during the first six years: A cost-of-illness study
16. Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: A 12 year study
17. Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting: The importance of drug and surgery costs
18. The total costs of drug therapy for rheumatoid arthritis. A model based on costs of drug, monitoring, and toxicity
19. The economic cost and social and psychological impact of musculoskeletal conditions
20. Mortality in rheumatoid arthritis: Have we made an impact in 4 decades?
21. Mortality in patients with rheumatoid arthritis
22. Mortality in rheumatoid arthritis patients with disease onset in the 1980s
23. Mortality in rheumatoid arthritis
24. Taking mortality in rheumatoid arthritis seriously - Predictive markers, socioeconomic status and comorbility
25. Longterm mortality outcome in patients with rheumatoid arthritis: Early presenters continue to do well
26. The mortality of rheumatoid arthritis
27. Analysis of methotrexate treatment effect in a longitudinal observational study: Utility of cluster analysis
28. The long-term outcomes of rheumatoid arthritis: A 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis
29. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
30. Current comment - Listening to the patient - A practical guide to self-report questionnaires in clinical care
31. Radiographic outcome of recent-onset rheumatoid arthritis: A 19-year study of radiographic progression
32. Health status questionnaires
33. The assessment and prediction of functional disability in RA
34. Measurement of patient outcome in arthritis
35. The Arthritis Impact Measurement Scales
36. Measuring health status in arthritis: The Arthritis Impact Measurement Scales
37. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis
38. The clinical and research significance of the erythrocyte sedimentation rate
39. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials
40. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis
41. Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology
42. Validity of single variables and indices to measure disease activity in rheumatoid arthritis
43. Development of a Disease Activity Score based on judgment in clinical practice by rheumatologist
44. A seven-day variability study of 499 patients with peripheral rheumatoid arthritis
45. Quantification of the manifestations of rheumatoid arthritis. 4. Area of joint surfaces as an index to total joint inflammation and deformity
46. A therapeutic score card for rheumatoid arthritis: A standardized method of appraising results of treatment
47. Self-administered joint counts and standard joint counts in the assessment of rheumatoid arthritis
48. Self-administered joint counts in rheumatoid arthritis: Comparison with standard joint counts
49. Patient self-report tender and swollen joint counts in early rheumatoid arthritis
50. What do self-administered joint counts tell us about patients with rheumatoid arthritis?
51. A self-report Thompson articular index: What does it measure?
52. Standardising joint assessment in rheumatoid arthritis
53. Validity and reproducibility of self-administered joint counts. A prospective longitudinal follow-up study in patients with rheumatoid arthritis
54. Joint assessment in rheumatoid arthritis
55. Joint counts and physical measures
56. Reduced joint counts in rheumatoid arthritis clinical trials
57. Reduced joint counts in controlled clinical trials in rheumatoid arthritis
58. Validity and reliability of joint indices - A longitudinal study in patients with recent onset rheumatoid arthritis
59. A self-report articular index - Relationship to variations in mood and disease activity measures
60. An electronic method for measuring joint tenderness in rheumatoid arthritis
61. Comparison of four articular indices for use in clinical trials in rheumatoid arthritis - Patient, order and observer variation
62. A simplified 28 joint quantitative articular index in rheumatoid arthritis
63. An experiment in reducing interobserver variability of the examination for joint tenderness
64. Significant changes in Ritchie scores
65. Articular indices of joint inflammation in rheumatoid arthritis. Correlation with the acute-phase response
66. Reduced joint count indices in the evaluation of rheumatoid arthritis
67. A simple pressure dolorimeter for the quantification of joint tenderness in inflammatory arthritis
68. Assessment of joint tenderness, grip strength, digital joint circumference and morning stiffness in rheumatoid arthritis
69. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis
70. Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system
71. A controlled trial of gold salt therapy in rheumatoid arthritis
72. Validity and reliability of the 28 joint count for the assessment of rheumatoid arthritis activity
73. Measurement of gold treatment effect in clinical practice: Evidence for effectiveness of intramuscular gold therapy
74. The visual analogue pain intensity scale: What is moderate pain in millimetres?
75. What is the maximum number of levels needed in pain intensity measurement?
76. A comparison of pain measurement characteristics of mechanical visual analogue and simple numerical rating scales
77. Reliability of pain scales in the assessment of literate and illiterate patients with rheumatoid arthritis
78. An evaluation of length and end-phrase of visual analogue scales in dental pain
79. Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale
80. Reproducibility along a 10 cm vertical visual analogue scale
81. Vertical or horizontal visual analogue scales
82. Ratio scales of sensory and affective verbal pain descriptors
83. Measurement of pain
84. The clinical value of the Stanford Health Assessment Questionnaire Functional Disability Index in patients with rheumatoid arthritis
85. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire
86. Self-report questionnaire scores in rheumatoid arthritis compared with traditional physical, radiographic, and laboratory measures
87. AIMS2. The content and properties of a revised and expanded Arthritis Impact Measurement Scales Health Status Questionnaire
88. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate
89. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: A double-blind, randomised, multicentre trial
90. Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial
91. Infliximab chimeric anti-tumour necrosis factor alpha monoclonal antibody versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial
92. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: A randomised trial
93. Combination treatment of rheumatoid arthritis using azathioprine and methotrexate: A 48 week controlled clinical trial
94. Antiinflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis - A randomized controlled trial
95. Compliance to drug treatment of patients with rheumatoid arthritis: A 3 year longitudinal study
96. Predicting the short term direct medical costs incurred by patients with rheumatoid arthritis
97. Early rheumatoid arthritis - Onset, course, and outcome over 2 years
98. Performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. II. A comparison of the SF-36 with disease-specific measures